| Literature DB >> 34012690 |
Wafaa Boumya1,2, Nawal Taoufik1, Mounia Achak2,3, Noureddine Barka3.
Abstract
Paracetamol is a non-steroidal, anti-inflammatory drug widely used in pharmaceutical applications for its sturdy, antipyretic and analgesic action. However, an overdose of paracetamol can cause fulminant hepatic necrosis and other toxic effects. Thus, the development of advantageous analytical tools to detect and determine paracetamol is required. Due to simplicity, higher sensitivity and selectivity as well as costefficiency, electrochemical sensors were fully investigated in last decades. This review describes the advancements made in the development of electrochemical sensors for the paracetamol detection and quantification in pharmaceutical and biological samples. The progress made in electrochemical sensors for the selective detection of paracetamol in the last 10 years was examined, with a special focus on highly innovative features introduced by nanotechnology. As the literature is rather extensive, we tried to simplify this work by summarizing and grouping electrochemical sensors according to the by which manner their substrates were chemically modified and the analytical performances obtained.Entities:
Keywords: Electrochemical sensors; Modified electrodes; Paracetamol; Pharmaceutical samples
Year: 2020 PMID: 34012690 PMCID: PMC8116204 DOI: 10.1016/j.jpha.2020.11.003
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Scheme 1Oxidation reaction of paracetamol to N-acetyl-p-benzoquinone imine.
Fig. 1Schematic representation of a chemically modified electrode, its interaction with the analyte, and the transduction of these interactions into measurable signals.
Fig. 2Various sensing materials used in electrochemical detection of PCT.
Fig. 3Common procedures used to modify carbon-based electrodes.
Advantages and disadvantages of the commonly used modification procedures.
| Technique | Advantages | Disadvantages |
|---|---|---|
| Paste mixing | -Simple operation, easy access to the equipment, and low cost. | -Needs care supervision to achieve reproducibility. |
| Drop-casting | -Inexpensive method. | -Films are not uniform. |
| Electrodeposition | -Cost-effective and time-saving. | -Process set up, current or voltage required. |
| Electrochemical polymerization | -Ease of synthesis. | -Difficult to remove film from electrode surface. |
Figure of merits of the carbon nanomaterials modified electrodes used in paracetamol analysis.
| Working electrode | Modification | Methods | Linearity (μM) | LOD (μM) | Application/Recovery (%) | Advantages | Disadvantages | Refs. |
|---|---|---|---|---|---|---|---|---|
| CPE | MWCNTs | SWV | 2–400 | 0.8 | Urine/101.25, 101.46 | B, C, D | C, D, F | [ |
| CPE | Gr | SWV | 2.5–143 | 0.6 | Tablet/96.95–99.24 | B, D | C, F | [ |
| GCE | GO | Amperometry | 0.1–430 | 0.021 | Human serum/99.6–99.9 | A, E | B, F | [ |
| GCE | Gr | SWV | 0.1–20 | 0.032 | Tablet/96.4–103.3 | A, B, D, E | F | [ |
| GCE | Gr nanoflakes | Amperometry | 0.001–300 | 0.00043 | Tablets/95.2–106.8 | A, B, E | F | [ |
| GCE | ERGO | SWV | 0.05–0.1 | 0.25 | Tablet/95–106 | B, D, E, F | D | [ |
| GCE | ERGO | Amperometry | 0.005–4 | 0.0021 | Human serum/96.08–103.2 | A, B, D, F | [ | |
| CPE | MWCNTs | DPV | 39.4–146.3 | 2.1 | Tablets/98–111 | B, C, E | D, F | [ |
| GCE | MWCNTs | SWV | 0.0002–15 | 0.00009 | Tablet/99 | A, B, C | F | [ |
| SPCE | MWCNT–COOH | FIA system | 0.25–10 | 0.1 | Tablets/95.5,105.38 | B, D | C, F | [ |
| GCE | MWCNT–COOH | DPV | 3–300 | 0.6 | Tablets/100.5–100.9 | C, D, E | D, F | [ |
| GCE | C60 | DPV | 50–1500 | 50 | Tablets/96–105 | B, D | A, C, D, F | [ |
| SPCE | C60 black | DPV | 1–300 | 0.01 | Tablets | A, B, C | C, F | [ |
| GCE | C60-MWCNT | DPV | 0.5–2000 | 0.035 | Tablets/99.25–100.16 | A, D | B, C, D, F | [ |
| GCE | N-CQDs | DPV | 0.5–600 | 0.157 | Tablets/95.07–98.56 | C, E | B, F | [ |
| GCE | CQDs-Gr | DPV | 0.001–10 | 0.00038 | Tablets/96.4–104.4 | A, D, E | B, F | [ |
Advantages: A: low LOD; B: easy electrode pretreatment/fabrication; C: simultaneous determination of PCT with two/more compounds; D: easier oxidation of paracetamol; E: long shelf-life of the sensor; F: economic electrode materials.
Disadvantages: A: complex electrode fabrication; B: high LOD; C: limited or unknown shelf-life stability of the sensor; D: unknown or insufficient interference tests; E: limited sensor reproducibility; F: expensive electrode materials; G: toxic electrode materials.
Fig. 4Schematic illustration of preparation procedures of electrochemically reduced graphene oxide-modified GCE. Reprinted with kind permission from Phong et al. [38].
PCT sensors based on non-carbon nanomaterials modified electrodes.
| Working electrode | Modifier | Methods | Linearity | LOD (μM) | Application/Recovery (%) | Advantages | Disadvantages | Refs. |
|---|---|---|---|---|---|---|---|---|
| CPE | ZSM-5/TiO2 | DPV | 2.5–110 | 0.58 | Human serum/98.21–102.35 | C, D, E | A, C, F | [ |
| CPE | Fe2O3 | DPV | 2–150 | 1.16 | Tablets/98.37–102.28 | C, D, E | B | [ |
| CPE | Au@Fe3O4 | DPV | 0.1–70 | 0.045 | Tablet/98.7–101.9 | A, E | A, F | [ |
| SPCE | Bi2O2 | DPV | 0.5–1250 | 0.03 | Tablets/98-103 | A, B, C, D | C, D | [ |
| GCE | Bi2O3 | CV | 0.5–1500 | 0.2 | Human blood/99.95–101 | B, F | C, D, E | [ |
| SPCE | CeO2 | DPV | 0.09–100 | 0.051 | Human serum/97.7–102 | A, B, E, F | G | [ |
| GCE | Fe2O3@SnO2 | DPV | 4.5–876 | 0.2 | Tablets/92–101.3 | C, E | C, F | [ |
| CPE | ZnFe2O4 | DPV | 6.5–135 | 0.4 | Tablet, Human serum | C, D, E | F | [ |
| CPE | ZnS | DPV | 1–15 | 0.041 | Tablet/96.8–100.4 | A, C, E | A | [ |
| GCE | Ni–Al/HCF-LDH | Amperometry | 3–1500 | 0.8 | Tablets, spiked serum/99.2–103 | C, D, E | A, F | [ |
| GCE | Au/SDS-LDH | DPV | 0.5–400 | 0.13 | Tablets/97.6–99 | D, E | A, F | [ |
| CPE | PANI/TPA | DPV | 0.9–1900 | 0.2 | Tablets/96–102.8 | C, D | A, C, D | [ |
| SPCE | PEDOT | FIA | 0.5–600 | 0.16 | Tablets/98–106.1 | B, E, F | B | [ |
| GCE | PEDOT | DPV | 2.5–150 | 1.13 | Tablets/97-107 | B, D, F | B, C | [ |
| GCE | Poly-AHMP | DPV | 2–20 | 0.15 | Tablets/96–102.75 | B, C, E | B | [ |
| GCE | Poly-( | Linear sweep voltammetry | 0.2–100 | 0.05 | Tablets/98.9–102.9 | A, B, D | F | [ |
| GCE | Poly-( | DPV | 0.8–100 | 0.077 | Ganmaoling granules/97.8–105.2 | A, D | A, F | [ |
| GCE | Poly-(diglycolic acid) | CV | 0.02–500 | 0.0076 | Tablets/99.1–101.8 | A, B, E | G | [ |
| GCE | Poly (nile blue) | DPV | 0.2–16.2 | 0.08 | Tablets/95.1–97 | A, C, D, E | F | [ |
| GCE | Poly(chromium Schiff base complex) | DPV | 0.008–0.125 | 0.0068 | Tablets/99–101.4 | A, B, C, D | C, F, G | [ |
Advantages: A: low LOD; B: easy electrode pretreatment/fabrication; C: simultaneous determination of PCT with two/more compounds; D: easier oxidation of paracetamol; E: long shelf-life of the sensor; F: economic electrode materials.
Disadvantages: A: complex electrode fabrication; B: high LOD; C: limited or unknown shelf-life stability of the sensor; D: unknown or insufficient interference tests; E: limited sensor reproducibility; F: expensive electrode materials; G: toxic electrode materials.
Fig. 5(A) Schematic illustration of the preparation of AuNPs@Fe3O4; (B) the stepwise procedure and electrochemical detection of PCT. Reproduced with permission from Ref. [56].
Analytical response characteristics of PCT sensors based on nanocomposite modified electrodes.
| Working electrode | Modifier | Methods | Linearity (μM) | LOD (μM) | Application/Recovery (%) | Advantages | Disadvantages | Refs. |
|---|---|---|---|---|---|---|---|---|
| GCE | GO-Pd | DPV | 0.005–80 | 0.0022 | Tablets/98.1–103.5 | A, B, E | F, G | [ |
| GCE | Au-Poly(CAF) | CV | 0.2–20 | 0.014 | Tablets/97.04–103.49 | A, B, D | C | [ |
| GCE | NGr-Pt | SWV | 0.05–90 | 0.008 | Tablets/94.88–105 | A, B, D | F, G | [ |
| GCE | RGO-Au@Pd | DPV | 1–250 | 0.30 | Tablets/98.4–103 | C, E | A, F, G | [ |
| GCE | Gr-Cu2O | SWV | 0.02–1.3 | 0.0067 | Tablets/97.3–103 | A, B, E | F, G | [ |
| GCE | RGO-Fe2O3 | DPV | 0.1–74 | 0.0021 | Tables/96.20–99.00 | A, B, E | F | [ |
| GCE | RGO-NCeO2 | DPV | 0.05–0.60 | 0.0098 | Tablets/99.84–100 | A, B, D, E | F, G | [ |
| CPE | Gr-NiFe2O4 | SWV | 0.01–9 | 0.003 | Tablets/98.7–102.7 | A, C, E | A, F | [ |
| CPE | Gr-CoFe2O4 | SWV | 0.03–12.0 | 0.025 | Tablets/97.8–102.0 | A, C, E | A, F | [ |
| GCE | ERGO-ZrO2 | LSV | 9–237 | – | Urine/96.2–97.4 | B, C, E | F | [ |
| GCE | ERGO-Ni2O3@NiO | DPV | 0.04–100 | 0.02 | Tablets/98.5–104.5 | A, E | B, D, F | [ |
| CPE | GO-Y2O3 | DPV | 7–400 | 1.45 | Tablets/99.26–104.50 | B, D | A, C | [ |
| SPCE | GO-Fe3O4@SiO2 | DPV | 0.5–100 | 0.1 | Tablets/98.7, 103.2 | C, D | A, C, D | [ |
| GCE | Gr-Nf | SW-AdASV | 0.0066–1.5 | 0.00086 | Tablets/98.3, 94 | A, B, C, D | C, D | [ |
| GCE | Gr-Nf | DPV | 0.05–20 | 0.031 | Urine/105 | A, C, E | B, F | [ |
| GCE | ERGO-Nf | SWV | 0.4–1 | 0.025 | Tablets/99–101 | A, B, D, E | F | [ |
| GCE | Gr-Cs | DPV | 1–100 | 0.3 | Tablets/92–107 | B, D | C, F | [ |
| GCE | RGO-Cs-CB | SWV | 2.8–19 | 0.053 | Urine/100–111 | A, C, D | B, C, F | [ |
| GCE | GO-NiO-Cs | SWV | 0.10–2.9 | 0.0067 | Urine/98, 100 | A, C, D | B, C, F | [ |
| CPE | GO-poly(Val) | DPV | 5–60 | 0.29 | Tablets/100.92–108.09 | C, D | C, D, F | [ |
| GCE | TiO2-Gr-poly(MR) | DPV | 0.25–50 | 0.025 | Tablets/97.2–104.2 | A, C, D, E | A, F | [ |
| GCE | Au@Gr-PEDOT | Amperometry | 0.15–5880 | 0.041 | Tablets | A, D, E | A, D, F | [ |
| CPE | Au-Nf | DPV | 0.05–50 | 0.0077 | Tablet/99.8–101.2 | A, B, D | C, D | [ |
| GCE | Ag-CB-PEDOT: PSS | SWV | 0.62–7.1 | 0.012 | Urine/95–104 | A, C, D | A, F, G | [ |
| CPE | PPy-CuO | DPV | 0.030–40 | 0.025 | Blood serum/98.5, 103.1 | A, B, C | C, D | [ |
| CPE | Co–S | DPV | 0.02–150 | 0.00099 | Tablets/99.4–101.8 | A, D, E | A, F | [ |
| CPE | MWCNT-Pt | AdSDPV | 0.351–56.10 | 0.028 | Tablets/98.7–100 | A, B, C, E | F | [ |
| CPE | MWNCT-Pt-TX100 | Amperometry | 0.09–10 | 0.0177 | Tablets/97–99 | A, D | A, F | [ |
| CPE | MWCNT/COOH–ZnO | DPV | 0.5–13 | 0.23 | Tablets/96-106 | C, D | A, D, F | [ |
| CPE | MWCNT-NiO-EF | SWV | 0.8–600 | 0.5 | – | C, D | A, F | [ |
| GCE | MWCNT-Au | DPV | 0.09–35 | 0.03 | Tablets/99.2, 100.6 | C, E | A, F | [ |
| GCE | MWCNT-Co | SWV | 0.0052–0.45 | 0.001 | Tablet/99.7 | A, B, C, E | D, F | [ |
| GCE | MWCNT-CoPhc-Au | SWV | 1.49–47.6 | 0.135 | Tablets/75.76–101.34 | D | A, C, D, F | [ |
| GCE | MWCNT-Ni(OH)2 | DPV | 0.06–26 | 0.017 | Urine/103, 103.5 | A, C | A, F | [ |
| GCE | MWCNT-Y2O3 | SWV | 0.0001–0.018 | 0.00003 | Tablet/101.5 | B, D, E | F | [ |
| GCE | MWCNT-SiO2 | DPV | 0.5–6 | 0.098 | Urine/98 | A, B, C, D | C, F | [ |
| GCE | MWCNT-Al2O3@SiO2 | SWV | 0.1–2 | 0.05 | Tablets/98.2–99.3 | A, D | A, C, D, F | [ |
| GCE | MWCNT-Poly(VP) | DPV | 0.02–450 | 0.00169 | Tablets/98.4–99.3 | A, B, E | F | [ |
| GCE | MWCNT-Poly(His) | DPV | 0.25–10 | 0.032 | Tablets/96.3–103.2 | A, B, C | C, D | [ |
| GCE | MWCNT-poly(Gly) | DPV | 0.5–10 | 0.5 | Tablets/99.2–101.05 Human serum/100.8–101.65 | B, C, D | C | [ |
| GCE | MWCNT-Cs | DPV | 2–250 | 0.16 | Human serum/96.2–100.8 | B, C, D | F | [ |
| GCE | MWCNT/COOH–Cs–Co | DPV | 0.1–400 | 0.01 | Tablets/99.26–99.76 | A, E | A, F | [ |
| GCE | MWCNT-Gr | DPV | 0.80–110 | 0.10 | Tablets/99.0–101 | C, D, E | A, F | [ |
| CPE | MWCNT-C60-Cu | SWV | 0.004–0.4 | 0.000073 | Human serum/99.21–99.87 | A, D, E | A, F | [ |
| GCE | SWCNT-Gr | DPV | 0.05–64.5 | 0.038 | Human serum/97.1–102.1 | A, D | A, F | [ |
| CPE | SWCNT-Nd2O3 | SWV | 0.10–9.5 | 0.05 | Tablet/92.6 | A, D | A, F | [ |
| GCE | MOF-199 | DPV | 20–300 | 1.3 | Tablets/96-107 | B, C | B, C, D, F | [ |
| CPE | MOF-Ferrocene | SWV | 0.01–20 | 0.0064 | Tablets/98.7–101.5 | A, D, E | A | [ |
| GCE | MOF-Au | DPV | 0.00001–100 | 0.0000011 | Tablets/101.1–102.5 | A, D, E | A, F | [ |
| GCE | Au-UiO-66-NH2 | DPV | 0.12–95.10 | 0.0494 | Tablets | A, D, E | A, F | [ |
| GCE | Cu, MOF-GO | DPV | 1–100 | 0.36 | Human serum/98–101 | D, E | A, F | [ |
Advantages: A: low LOD; B: easy electrode pretreatment/fabrication; C: simultaneous determination of PCT with two/more compounds; D: easier oxidation of paracetamol; E: long shelf-life of the sensor; F: economic electrode materials.
Disadvantages: A: complex electrode fabrication; B: high LOD; C: limited or unknown shelf-life stability of the sensor; D: unknown or insufficient interference tests; E: limited sensor reproducibility; F: expensive electrode materials; G: toxic electrode materials.
Fig. 6Schematic representation of sensor fabrication. Reproduced with permission from Ref. [116].
Modified boron-doped diamond electrodes and carbon-ceramic electrodes for paracetamol analysis.
| Working electrode | Modifier | Methods | Linearity (μM) | LOD (μM) | Application/Recovery (%) | Advantages | Disadvantages | Refs. | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BDDE | Nf-Pb | DPV | 0.5–200 | 0.175 | Tablet/100.04 | B, C, D | C, G | [ | ||
| BDDE | Nf-Pb | DPV | 0.5–1000 | 0.14 | Human urine/102.5–104.67 | B, C, E | G | [ | ||
| BDDE | Nf-Bi | DPV | 0.2–1000 | 0.0262 | Tablet/105.14 | A, B, C | C, G | [ | ||
| CCE | SWCNT | DPV | 0.2–150 | 3 | Tablet/98.79–101.51 | B, C, E | B, F | [ | ||
| CCE | SWCNT | DPV | 0.08–200.0 | 0.05 | Tablets/97.23–101.7 | A, B, C, D | F | [ | ||
| CCE | SWCNT | DPV | 0.04–58 | 0.025 | Tablets/97.23–101.81 | A, B, D, E | F | [ | ||
| MWCNT | DPV | 0.1–6500 | 0.080 | |||||||
| CCE | SWCNT | DPV | 0.2–100.0 | 0.12 | Tablets/97.23–101.81 | B, C, D | C, F | [ | ||
| CCE | Co oxides | FIA system | 5–35 | 0.37 | Tablets/96-103 | B, D | C, G | [ | ||
| CCE | Gr-Ionic liquid | DPV | 0.1–20 | 0.063 | Tablets/96.2–102.3 | A, C, E | A | [ | ||
Advantages: A: low LOD; B: easy electrode pretreatment/fabrication; C: simultaneous determination of PCT with two/more compounds; D: easier oxidation of paracetamol; E: long shelf-life of the sensor; F: economic electrode materials.
Disadvantages: A: complex electrode fabrication; B: high LOD; C: limited or unknown shelf-life stability of the sensor; D: unknown or insufficient interference tests; E: limited sensor reproducibility; F: expensive electrode materials; G: toxic electrode materials.